@article{fd88cbf298ef4638866df2085ede7a3f,
title = "The editors roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation",
author = "Friedewald, {Vincent E.} and Fonarow, {Gregg C.} and Brian Olshansky and Yancy, {Clyde W.} and Roberts, {William C.}",
note = "Funding Information: Dr. Friedewald has received honoraria for speaking from Novartis, East Hanover, New Jersey. Dr. Fonarow has received honoraria for speaking and consulting and research grants from Medtronic; and GlaxoSmithKline, Research Triangle Park, North Carolina. Dr. Olshansky has received honoraria for speaking and consulting from Medtronic; and Boston Scientific Corporation, Natick, Massachusetts. Dr. Olshansky has received honoraria for consulting and is a member of the advisory board for Novartis. Dr. Yancy has no relevant financial relationships to disclose. Dr. Roberts has received honoraria for speaking from Merck, Whitehouse Station, New Jersey; AstraZeneca, Wilmington, Delaware; and Novartis. ",
year = "2011",
month = feb,
day = "15",
doi = "10.1016/j.amjcard.2010.10.003",
language = "English (US)",
volume = "107",
pages = "583--590",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",
}